Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

The FDA has approved the at-home use of FluMist, a nasal spray flu vaccine, available in fall 2025. Effective for healthy people aged 2 to 49, it offers a needle-free option but isn't suitable for ...

Is FluMist, the at-home nasal vaccine that was recently approved by the FDA, as effective at preventing illness as traditional flu shots? Here's what health experts think.

The FDA approved FluMist as the first flu vaccine that can be self-administered at home.

The U.S. Food and Drug Administration (FDA) has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver, the agency announced. FluMist has been in use for ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the ...

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves.

The nasal spray version of the flu vaccine, sold as FluMist, will be available for use at home starting next year. (AFP/Getty Images) ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the regulator said.

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...